magnesium sulfate has been researched along with Spinal Cord Injuries in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 9 (64.29) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akçakaya, MO; Aras, Y; Aydoseli, A; Can, H; Canbolat, A; Gömleksiz, C; Sencer, A | 1 |
Afshari, K; Farsi, L; Keshavarz, M; Memari, F; NaghibZadeh, M; Norouzi-Javidan, A | 1 |
Afshari, K; Farsi, L; Ghajarzadeh, M; Keshavarz, M; Naghib Zadeh, M; Naghshband, Z; Norouzi-Javidan, A | 1 |
Aarabi, B; Fehlings, MG; Grossman, RG; Guest, J; Harrop, JS; Hashimoto, R; Norvell, D; Raich, A; Tator, CH | 1 |
Beskonakli, E; Kaptanoglu, E; Okutan, O; Selcuk Surucu, H; Taskin, Y | 1 |
Beskonakli, E; Kaptanoglu, E; Kilinc, A; Solaroglu, I; Taskin, Y | 1 |
Cui, YJ; Ishida, K; Kaneko, S; Matsumoto, M; Ohtake, K; Saeki, H; Sakabe, T; Tsuruta, S | 1 |
Attar, A; Beskonakli, E; Kaptanoglu, E; Kilinc, K; Okutan, O; Solaroglu, I | 1 |
Cengiz, SL; Gürbilek, M; Oğün, TC; Ozdemir, M; Ustün, ME | 1 |
Ditor, DS; John, SM; Kittmer, C; Marx, JC; Roy, J; Weaver, LC | 1 |
Beskonakli, E; Gok, B; Kilinc, K; Okutan, O | 1 |
Coskun, E; Islekel, H; Süzer, T; Tahta, K | 1 |
Izena, H; Kanazawa, K; Maehama, T | 1 |
Jones, NA; Jones, SD | 1 |
1 review(s) available for magnesium sulfate and Spinal Cord Injuries
Article | Year |
---|---|
Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.
Topics: Animals; Disease Models, Animal; Glyburide; Humans; Magnesium Sulfate; Minocycline; Neuroprotective Agents; Nimodipine; Riluzole; Spinal Cord Injuries; Translational Research, Biomedical | 2012 |
13 other study(ies) available for magnesium sulfate and Spinal Cord Injuries
Article | Year |
---|---|
Effects of combined and individual use of N-methyl-D aspartate receptor antagonist magnesium sulphate and caspase-9 inhibitor z-LEDH-fmk in experimental spinal cord injury.
Topics: Animals; Apoptosis; Caspase Inhibitors; Disease Models, Animal; Magnesium Sulfate; Male; Necrosis; Neuroprotective Agents; Oligopeptides; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord Injuries | 2013 |
Postinjury treatment with magnesium sulfate attenuates neuropathic pains following spinal cord injury in male rats.
Topics: Analgesics; Animals; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Magnesium Sulfate; Male; Neuralgia; Rats; Spinal Cord Injuries | 2015 |
Effects of combining methylprednisolone with magnesium sulfate on neuropathic pain and functional recovery following spinal cord injury in male rats.
Topics: Animals; Drug Therapy, Combination; Laminectomy; Magnesium Sulfate; Male; Methylprednisolone; Neuralgia; Neuroprotective Agents; Rats; Recovery of Function; Spinal Cord Injuries | 2015 |
Effect of magnesium sulphate in experimental spinal cord injury: evaluation with ultrastructural findings and early clinical results.
Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; Edema; Female; Magnesium Sulfate; Motor Activity; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries | 2003 |
Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results.
Topics: Animals; Capillary Permeability; Disease Models, Animal; Female; Magnesium Sulfate; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Spinal Cord Vascular Diseases; Time Factors | 2003 |
Is intrathecal magnesium sulfate safe and protective against ischemic spinal cord injury in rabbits?
Topics: Anesthesia; Animals; Blood Pressure; Body Temperature; Cell Count; Hindlimb; Injections, Spinal; Locomotion; Magnesium Sulfate; Motor Neurons; Neuroprotective Agents; Rabbits; Reperfusion Injury; Sensation; Spinal Cord; Spinal Cord Injuries; Spinal Cord Ischemia | 2004 |
Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Female; Magnesium Sulfate; Methylprednisolone Hemisuccinate; Neuroprotective Agents; Rats; Rats, Wistar; Spinal Cord Injuries | 2005 |
Effects of magnesium sulfate on spinal cord tissue lactate and malondialdehyde levels after spinal cord trauma.
Topics: Animals; Blood Pressure; Carbon Dioxide; Heart Rate; Lactic Acid; Magnesium Sulfate; Malondialdehyde; Oxygen; Rabbits; Random Allocation; Spinal Cord; Spinal Cord Injuries | 2005 |
Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat.
Topics: Analysis of Variance; Animals; Autonomic Dysreflexia; Drug Therapy, Combination; Locomotion; Magnesium Sulfate; Male; Nerve Crush; Nerve Fibers, Myelinated; Neuroprotective Agents; Pain Threshold; Polyethylene Glycols; Random Allocation; Rats; Rats, Wistar; Recovery of Function; Spinal Cord Injuries; Statistics, Nonparametric; Thoracic Vertebrae; Time Factors; Treatment Outcome | 2007 |
Effects of magnesium sulphate following spinal cord injury in rats.
Topics: Animals; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Magnesium Sulfate; Methylprednisolone; Neuroprotective Agents; Neutrophil Infiltration; Peroxidase; Random Allocation; Rats; Rats, Wistar; Spinal Cord Injuries | 2007 |
Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury.
Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Evoked Potentials, Somatosensory; Injections, Subcutaneous; Lipid Peroxidation; Magnesium Sulfate; Male; N-Methylaspartate; Neuroprotective Agents; Random Allocation; Rats; Spinal Cord Injuries; Statistics, Nonparametric | 1999 |
Management of autonomic hyperreflexia with magnesium sulfate during labor in a woman with spinal cord injury.
Topics: Adult; Autonomic Dysreflexia; Female; Humans; Labor, Obstetric; Magnesium Sulfate; Pregnancy; Pregnancy Complications; Spinal Cord Injuries | 2000 |
Management of life-threatening autonomic hyper-reflexia using magnesium sulphate in a patient with a high spinal cord injury in the intensive care unit.
Topics: Adult; Autonomic Dysreflexia; Calcium Channel Blockers; Chronic Disease; Critical Care; Humans; Magnesium Sulfate; Male; Spinal Cord Injuries | 2002 |